| Nov 18 |
US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug
|
| Nov 18 |
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
|
| Nov 18 |
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
|
| Nov 6 |
Are Medical Stocks Lagging Bausch Health (BHC) This Year?
|
| Nov 4 |
Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term
|
| Nov 1 |
Bausch Health Q3 Earnings and Revenues Top, Xifaxan Boosts Sales
|
| Oct 31 |
Bausch Health Companies Inc (BHC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
|
| Oct 31 |
Bausch Health Companies Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Oct 31 |
Bausch Health Companies, Inc. (BHC) Q3 2024 Earnings Call Transcript
|
| Oct 31 |
Compared to Estimates, Bausch (BHC) Q3 Earnings: A Look at Key Metrics
|
